Sign In
Buy FOLD
$14.49
+0 (+0%)
At Close: Jun 03, 2026
The
Will Amicus Therapeutics (FOLD) Report Negative Earnings Next Week? What You Should Know
04:31pm, Monday, 03'rd Aug 2020
Amicus Therapeutics (FOLD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 31st
11:42am, Friday, 31'st Jul 2020
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.
Amicus Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020
11:00am, Tuesday, 28'th Jul 2020
CRANBURY, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Monday, August 10, 2020 at 8
Applied DNA's COVID-19 Vaccine, And Other News: The Good, Bad And Ugly Of Biopharma
07:34am, Monday, 20'th Jul 2020
Applied DNA reports positive preclinical results for COVID-19 vaccine. Berkeley Lights shows impressive debut on NASDAQ.
The Amicus Therapeutics (NASDAQ:FOLD) Share Price Has Gained 16% And Shareholders Are Hoping For More
12:04pm, Friday, 17'th Jul 2020
If you want to compound wealth in the stock market, you can do so by buying an index fund. But if you pick the right...
Amicus Therapeutics Secures $400 Million Non-Dilutive Debt Financing
11:32am, Friday, 17'th Jul 2020
$400M Debt Facility Provides Path to Profitability Without the Need for Any Future Dilutive Financings Self-sustainable Financial Profile Achieved with Comprehensive, Low Cost.
After near-total shut down of rail links, trains worldwide get green light
03:20pm, Thursday, 16'th Jul 2020
One new international night train, from Prague to Rijeka, is proving so popular that it has been expanded from three departures each week to a daily service
DNB Asset Management AS Acquires New Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)
05:34am, Tuesday, 14'th Jul 2020
DNB Asset Management AS acquired a new stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) in the 2nd quarter, according to its most recent filing with the SEC. The fund acquired 56,768 shares of the bio
Did Hedge Funds Make The Right Call On Amicus Therapeutics, Inc. (FOLD)?
12:16am, Monday, 13'th Jul 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
12:00am, Thursday, 09'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 8)
Akero Therapeutics Inc (...
With Its Film Fest Postponed by the Pandemic, Rare-Disease Group Starts Its Own Streaming Channel
12:00am, Wednesday, 08'th Jul 2020
Rare Outreach Coalition has launched The Disorder Channel to showcase rare disease films and videos for free on Roku® and Amazon Fire TV.
Axa Decreases Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)
05:26am, Monday, 06'th Jul 2020
Axa decreased its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) by 48.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund
AQR Capital Management LLC Lowers Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD)
07:18am, Saturday, 04'th Jul 2020
AQR Capital Management LLC lessened its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) by 4.4% in the first quarter, according to the company in its most recent filing with the Securities & Excha
Invesco Ltd. Sells 5,228,451 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)
06:28am, Friday, 03'rd Jul 2020
Invesco Ltd. reduced its holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) by 80.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Comm
